Evidence map›Paper›PMID 34096266›Full record

ArticleBiochemistry2021

Revisiting Nitric Oxide Signaling: Where Was It, and Where Is It Going?

Michael A Marletta

Abstract readHistorical Article
In one paragraph

Article in Biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  7. Metalloprotein enabled redox signal transduction in microbes.Current opinion in chemical biology · 2023
    Review
  8. Review
  9. Review
  10. Radicals in Biology: Your Life Is in Their Hands.Journal of the American Chemical Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael A MarlettaDepartments of Chemistry and Molecular and Cell Biology, University of California, Berkeley, California 94720-3220, United States.ORCID 0000-0001-8715-4253

Funding

Activation Mechanism of Soluble Guanylate CyclaseR01GM127854 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARLETTA, MICHAEL A. · 2019 to 2022
$1.3M
NIGMS NIH HHS R01 GM127854
6 · The paper itself

Abstract

Nitric oxide (NO) has long been known to be an intermediate in bacterial pathways of denitrification. Only in the middle to late 1980s was it found to play a central role in a much broader biological context. For example, it is now well established that NO acts as a signaling agent in metazoans, including humans, yet NO is toxic and very reactive under biological conditions. How is the biology in which NO plays a role controlled? How is NO used and the inherent toxicity avoided? Looking back at the initial discovery time, to the present, and on to the future provides many answers to questions such as those listed above.

Indexed as

Signal TransductionAnimalsAnionsBacteriaBiochemistryHistory, 20th CenturyHumansMetabolic Networks and PathwaysNitric OxideNitric Oxide SynthaseSoluble Guanylyl CyclaseAnionsNitric OxideNitric Oxide SynthaseSoluble Guanylyl Cyclase

Identifiers

PMID34096266
PMCPMC8714492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.